Cardiff Oncology (CRDF) Gets a Buy From Piper Sandler
TipRanksMay 3 20:18
Cardiff Oncology Analyst Ratings
BenzingaMar 6 19:48
HC Wainwright & Co. Maintains Buy on Cardiff Oncology, Raises Price Target to $14
BenzingaMar 6 19:49
Piper Sandler Maintains Overweight on Cardiff Oncology, Raises Price Target to $7
BenzingaMar 1 23:02
Cardiff Oncology Analyst Ratings
BenzingaMar 1 23:01
Cardiff Oncology (CRDF) Gets a Buy From Piper Sandler
TipRanksMar 1 20:48
Positive Clinical Trials and Financial Stability Propel a Buy Rating for Cardiff Oncology: An Insight Into the Anticipated Success of CRDF-004 and CRDF-005 Trials
TipRanksNov 7, 2023 22:45
Cardiff Oncology (CRDF) Gets a Buy From Piper Sandler
TipRanksNov 3, 2023 18:44
Cardiff Oncology (CRDF) Receives a Buy From TD Cowen
TipRanksNov 3, 2023 06:56
Cardiff Oncology's Onvansertib Shows Promise: An Analysis of the Buy Rating Recommendation
TipRanksSep 29, 2023 14:27
Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT), Cardiff Oncology (CRDF) and Streamline Health Solutions (STRM)
TipRanksSep 27, 2023 21:10
Piper Sandler Sticks to Its Buy Rating for Cardiff Oncology (CRDF)
TipRanksSep 27, 2023 19:07
Cardiff Oncology (CRDF) Receives a Buy From Robert W. Baird
TipRanksAug 12, 2023 00:15
HC Wainwright & Co. Maintains Buy on Cardiff Oncology, Lowers Price Target to $12
BenzingaAug 11, 2023 19:15
Cardiff Oncology Analyst Ratings
BenzingaAug 11, 2023 19:14
H.C. Wainwright Sticks to Their Buy Rating for Cardiff Oncology (CRDF)
TipRanksAug 8, 2023 19:25
Cardiff Oncology Analyst Ratings
BenzingaAug 8, 2023 19:22
HC Wainwright Trims Cardiff Oncology Price Target to $14 From $15, Maintains Buy Rating
MT NewswiresMay 9, 2023 21:53
HC Wainwright & Co. Maintains Buy on Cardiff Oncology, Lowers Price Target to $14
BenzingaMay 9, 2023 19:07
HC Wainwright & Co. Reiterates Buy on Cardiff Oncology, Maintains $15 Price Target
BenzingaMar 29, 2023 18:50
No Data
No Data